Seven years old male child (24 kg weight) diagnosed as a case of sub acute appendicitis treated with ciprofl oxacin, immediately developed multiple erythmatous papules. Reaction subsided after withholding ciprofl oxacin and treatment with dexamethasone and chlorpheneramine maleate. It was developed again when treated with levofl oxacin and subsided after withdrawal. IgE binding at 7 th position of core structure of fl uoroquinolones likely to be the mechanism. As all the fl uoroquinolones have similar core structure, hypersensitivity to one may have cross sensitivity to other fl uoroquinolones. It is advisable to avoid other fl uoroquinolones and switch over to other group of antibiotics when hypersensitivity to one occurs. Website: www.jpharmacol.com
INTRODUCTION
Cross sensitivity is defi ned as sensitivity to one substance that renders an individual sensitive to other substances of similar chemical structure. [1] Cross sensitivity has been reported commonly among various β lactam antibiotics and sulfonamides. [2, 3] For the diagnosis of cross sensitivity, various methods like prick test, patch test and histamine release test are available. Oral challenge test is considered as the most reliable. [4] Due to broad antimicrobial spectrum, favorable pharmacokinetic properties and few adverse drug reactions, fl uoroquinolones are widely used. Frequently reported adverse reactions with fl uroquinolones are nausea, abdominal pain, diarrhea, dizziness, restlessness, headache, depression and somnolence or insomnia. [5] Hypersensitive reactions are rare (0.4% to 2%) due to fl uoroquinolones. [4, 6] Immediate type of reactions are more common than delayed type of reactions. Frequently reported immediate hypersensitive reactions are urticaria, anaphylactic shock, rashes and erythema. [4] Ciprofl oxacin and norfl oxacin are the most common drugs causing hypersensitivity reactions, while levofl oxacin is the least common with incidence of 1 per million population. [4, 7] Fixed drug eruption by ciprofl oxacin with cross sensitivity to norfl oxacin has been reported. [8] However, we could not fi nd a case of immediate hypersensitivity reaction with levofl oxacin or case report of cross sensitivity between ciprofl oxacin and levofl oxacin. Here with, we report a case of cross sensitivity between ciprofl oxacin and levofl oxacin for immediate type of hypersensitive reaction.
CASE REPORT
Seven years old male child (24 kg weight) admitted in paediatric ward, Sir Takhtsinhji General Hospital, Government Medical College, Bhavnagar, Gujarat, India with complaints of fever, headache, vomiting and abdominal pain for 7 days. Fever was of high grade, intermittent and associated with chills, which was followed by colicky abdominal pain. He had a past history of similar attacks two times, at that time pain was relieved after oral treatment. There was no past history of drug allergy. Provisional diagnosis of subacute appendicitis was made.
On examination, temperature was raised; tenderness was present in the right iliac fossa. Various investigations like hemoglobin, total and differential WBC count, platelet count, ESR, urine and stool examination were normal. Peripheral smear for malaria parasites, Mantoux test and Widal's test were negative. USG abdomen was suggestive of appendicitis. As per surgical opinion conservative treatment was started with ciprofl oxacin infusion (20mg/kg/day in two divided doses), inj. metronidazole (30mg/kg/day, in three divided doses), inj. ondansetron (0.1mg/kg, as and when required) and tab. paracetamol (10mg/kg, as and when required). Five minutes after starting infusion of ciprofl oxacin, patient developed itching followed by rashes at the site of infusion. On dermatological examination, multiple erythmatous papules and plaques were present on the arm and chest. Reaction started from the site of injection and spread upward involving whole arm up to chest. Infusion was stopped immediately and injection dexamethasone (0.5mg/kg) was given along with injection chlorphenaramine maleate (0.1mg/kg). After two hours rashes subsided and metronidazole infusion started. Patient was kept under observation, no adverse reaction seen with metronidazole. Levofl oxacin (10mg/kg/day) was added in treatment in place of ciprofl oxacin from next day under close observation. Immediately after levofl oxacin infusion, itching and rashes in arm appeared so, infusion was withdrawn. This time reaction occurred within few seconds. No rescue treatment required and reaction abated after stopping the infusion. Ceftriaxone (100mg/kg/day) injection added in the place of fl uoroquinolones along with metronidazole.
Reaction was probable according to naranjo's scale. [9] It was moderate in severity according to Modifi ed Hartwig and Siegel's scale [10] and non preventable as per Modifi ed Schumock and Thornton scale. [11] 
DISCUSSION
All fl uoroquinolones have similar core structure (4-oxo-1, 4-dihydroquinoline ring) with fluorine atom attached at position 6 except, fi rst generation quinolone, nalidixic acid. Norfl oxacin, a second generation fl uroquinolone, is the result of replacement at C-7 methyl side chain with piperazine group, while replacement of N-1 ethyl group of norfl oxacin with cyclopropyl group generates ciprofl oxacin. Levofl oxacin, third generation fl ouroquinolone, has modifi cation of piperazine group with methyl group at C-7. Moxifloxacin is fourth generation fl ouroquinolone having methoxy group at C-8 position. Although changes in position 1, 7 and 8 generated different fl uoroquinolones, core structure remains same. [12, 13] 54.5% immediate type of reactions to fl uoroquinolones are IgE mediated and occurs due to binding of IgE to 7 th position of core structure of fl uoroquinolones. [4] Patient had a past history of two similar attacks, at that time he might be treated with fl uoroquinolones, which may resulted in production of IgE antibodies. As a result, treatment with fl uoroquinolones this time might have caused the reaction. Ciprofl oxacin and levofl oxacin have similar core structure; this may be the reason for the cross sensitivity in this case. It is advisable to avoid other fl uoroquinolones when hypersensitivity reaction detected to one and should be shifted to other class of antimicrobials. Overall risk of adverse effects especially hypersensitivity reactions with fl uoroquinolones is low but due to widespread use, such rare hypersensitivity reactions should be kept in mind. Improvement in diagnostic tests like detection of IgE antibodies, cellular tests and skin test may help in preventing such adverse drug reactions.
